Los Angeles Capital Management LLC Atara Biotherapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$14.7 - $19.89 $360,017 - $487,125	-24,491 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$11.99 - $17.9 $563,769 - $841,657	-47,020 Reduced 65.75%	24,491 $438,000
Q2 2021 Aug 05, 2021	SELL	$12.89 - $16.58 $56,587 - $72,786	-4,390 Reduced 5.78%	71,511 $1.11 Million
Q1 2021 May 05, 2021	BUY	$14.0 - $20.72 $351,092 - $519,616	25,078 Added 49.34%	75,901 $1.09 Million
Q4 2020 Feb 04, 2021	BUY	$12.67 - $26.23 $74,309 - $153,838	5,865 Added 13.05%	50,823 $998,000
Q3 2020 Nov 02, 2020	BUY	$11.92 - $15.87 $16,092 - $21,424	1,350 Added 3.1%	44,958 $583,000
Q2 2020 Aug 05, 2020	BUY	$7.53 - $14.93 $242,202 - $480,223	32,165 Added 281.09%	43,608 $635,000
Q1 2020 May 04, 2020	BUY	$5.69 - $17.78 $65,110 - $203,456	11,443 New	11,443 $97,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.